Three cysteine-rich cationic peptides, designated RatNP-1, RatNP-3, and RatNP-4, were purified from an acid extract of rat polymorphonuclear neutrophils, sequenced, and tested for antimicrobial activity. The peptides ranged from 29 to 32 amino acids in length (Mrs 3,252 to 3,825), and each contained all eight invariantly conserved "framework" residues that are characteristic of defensins. Each of the peptides killed Escherichia coli ML-35, Acinetobacter calcoaceticus HON-1, Staphylococcus aureus 502A, and Candida albicans 820 in vitro. RatNP-1, the most cationic rat defensin, was also the most potent. With this report, a total of 13 distinct defensins have been characterized in the polymorphonuclear leukocytes of four mammalian species.
Polymorphonuclear leukocytes (PMN) are major effectors in host defenses against bacteria and fungi. Their ability to kill ingested microorganisms depends on both the generation of toxic microbicidal oxidants (2, 9, 20) and the delivery of preformed antimicrobial proteins or peptides (12, 34, 36) from their cytoplasmic granules to phagosomes. A recently characterized family of small, cysteine-rich peptides (defensins) are prominent among the antimicrobial molecules contained within human, guinea pig, or rabbit PMN (13, (37) (38) (39) (40) 42) . Their relative abundance, widespread distribution, and broad antimicrobial spectrum-which includes bacteria (13, 39, 42) , fungi (13, 23, 35, 39, 41) , and some enveloped viruses (6, 13, 22, 39) -suggest that defensins may play significant roles in PMN-mediated host defenses.
Although defensins have not heretofore been described in rat PMN, Modrzakowski et al. reported that an extract prepared from rat PMN exerted antibacterial activity against certain bacteria (17, 18, 24, 25, 28) , and they associated the activity of these extracts with small cationic peptides. Because rats are widely used in experimental models of infection, precise characterization of their antimicrobial effector molecules is desirable. In this communication, we describe the purification and primary structures of three rat PMN defensins and provide preliminary evidence of their broad antimicrobial spectrum.
MATERIALS AND METHODS
Purification of PMN. To elicit peritoneal neutrophils, Sprague-Dawley rats were injected intraperitoneally with normal saline solution containing 7.5% sodium caseinate (Eastman Kodak Co., Rochester, N.Y.) in a dose of 0.4 ml/10 g of body weight (3) . Six hours later the rats were sacrificed, and peritoneal exudate cells were obtained by lavaging the peritoneal cavity of each rat with 40 ml of Dulbecco phos-* Corresponding author.
phate-buffered saline that contained 5 mM glucose and 5 U of heparin per ml (DPBS). The lavage fluids were centrifuged at 200 x g for 10 min at 4°C, and the pelleted cells were suspended in DPBS. Erythrocytes were removed by brief hypotonic lysis in ice-cold distilled water. After centrifugation, the PMNs were suspended in DPBS. lyophilized in a vacuum centrifuge, and further purified by reversed-phase high-performance liquid chromatography (RP-HPLC) on a C-18 column (4.6 by 250 mm, Vydac; The Separation Group, Hesperia, Calif.) with a water-acetonitrile gradient that contained 0.1% trifluoroacetic acid as previously described (42) . Purity of the peptides was assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), AU-PAGE, and RP-HPLC.
Composition analysis. Each peptide was reduced and subsequently alkylated with iodoacetamide in 6.0 M guanidine hydrochloride-0.5 M Tris hydrochloride (pH 8.1)-0.2 mM EDTA as previously described (15) . The carboxamidomethylated peptides were desalted by RP-HPLC on a 4.6-by 250-mm C-18 column (Vydac). Performic acid-oxidized, carboxamidomethylated, or native peptides were hydrolyzed under vacuum in 5.7 N HCl for 24 to 72 h. Amino acids were quantitated as phenylthiocarbamyl derivatives by RP-HPLC on a C-18 column as previously described (40) . The assay for free sulfhydryls was performed spectrophotometrically with Ellman reagent (16) , and carbohydrate content was estimated by the phenol-sulfuric acid assay (8) .
Sequence determination. The S-carboxamidomethylated peptides (2 to 4 nmol) were sequenced on a model 475A sequencing system (Applied Biosystems, Inc., Foster City, Calif.), as previously described (37) counting, samples were removed, appropriately diluted, and spread on Sabouraud agar plates with a spiral spreader. C. allbi( (ns colonies were counted 24 to 48 h later; C. nieoJormtanS colonies were counted after 72 h.
Direct viral neutralization. The ability of rat granulocyte defensins to directly inactivate type 1 herpes simplex virus (McIntyre strain) was tested as previously described (6, 22) .
RESULTS
Peptide purification. AU-PAGE revealed that our initial acid extract of rat PMN contained five prominent cationic peptides ( Fig. 1 ) that were designated rat neutrophil peptide 1 (RatNP-1) through -5, in order of their relative cathodal migration. Two of these peptides, RatNP-2 and -5, were substantially less abundant than the others and were not available in sufficient quantities for sequencing and functional testing. To determine whether any of the other three peptides was a defensin, we chromatographed the crude extract on Bio-Gel P-10 and examined their contents by AU-PAGE and SDS-PAGE. The fractions containing 
RatNP-1, -3, and -4 of the crude extract were purified to homogeneity by RP-HPLC (Fig. 2) . The purity of the three peptides was confirmed by AU-PAGE (Fig. 1) . RP-HPLC (Fig. 2) , and SDS-PAGE (data not shown).
Characterization of rat peptides. The amino acid composition of RatNP-1. -3, and -4 revealed that each had a relatively high content of cysteine and arginine (Table 1) , as had previously been noted for rabbit, human, and guinea pig defensins (37, 39, 40) . Lysine and tryptophan residues were absent. RatNP-4 lacked the phenylalanine residue present in RatNP-1 and -3. Although RatNP-2 and -5 were not fully purified and sequenced, preliminary amino acid analyses suggest that these may also prove to be defensins (data not shown). In other experiments, we found that these rat neutrophil peptides were especially abundant in subcellular granule-rich fractions of rat PMN, consistent with the localization of defensins in human, rabbit, and guinea pig leukocytes (data not shown).
The molecular weights of RatNP-1, -3, and -4 as estimated by SDS-PAGE (data not shown) were consistent with the values obtained from the amino acid composition and sequence data shown in Table 1 . Figure 3 compares the primary amino acid sequences of RatNP-1, -3, and -4 with the primary amino acid sequences of 10 other known defensins (37, 39, 40) : note that all six cysteines in each rat peptide align precisely with the invariant cysteine residues of the other defensins. Figure 4 shows the remarkable similarity of RatNP-4 to the human defensin HNP-1; 17 of their residues coincided precisely, and another 6 were conservatively replaced. Given their size. cationicity, abundance in granulocytes, homologies, and especially their fully conserved cysteine motif, it is clear that RatNP-1, -3. and -4 are defensins.
Antimicrobial activity. Because the previously described members of the defensin family exerted antimicrobial activity in vitro, we examined the effects of the three rat defensins on selected bacteria and fungi (Table 2 ). Each rat defensin was more potent against E. coli ML-35 than the human PMN defensin HNP-1. Note that the relative efficacy of these rat defensins was in the same order of their net cationicity (positive charge): RatNP-1 > RatNP-2 > RatNP-4 (Fig. 5) . All three rat neutrophil peptides also killed >90% of A. all(oa(eticius in 2 h when tested at 50 p.g/ml under our standard incubation conditions (data not shown).
Midlogarithmic-phase S. aiiiieiis 502A was also highly sensitive to the bactericidal activity of RatNP-1 (Table 2 . Fig. 3 . The identical residues are enclosed; c, conservative substitutions. Fig. 6 ). At a concentration of 1 p.g/ml, RatNP-1 caused a 2-log1o-unit decrease in S. allreis CFU per milliliter, whereas 2.5 jtg/ml reduced the viable counts by 5 log1, units.
RatNP-1 was also effective against stationary-phase S. aiureus; however, 10 (2, 20) . These oxidants act directly or in concert with other PMN components to destroy invading microbes (2, 20) .
The nonoxidative antimicrobial mechanisms of PMN arise, in part, from the effects of antimicrobial proteins or peptides sequestered within the cytoplasmic granules of the PMN (12, 34) . Among these antimicrobial effector molecules are lysozyme (5, 11) , cathepsin G (29-31), bactericidal permeability-increasing protein (BPI) (10) and related or additional factors (19, 21) , and defensins (13, (37) (38) (39) 42) . Additional types of antimicrobial peptides have recently been reported to exist in bovine PMN (26, 33) .
The structural and functional attributes of the three rat peptides described in this report establish their identity as members of the defensin peptide family. Like other defensins (6, 13, 35, 39, 41, 42) , the rat peptides displayed antimicrobial activity against a broad spectrum of microbial targets. These included S. aureus 502A, two gram-negative bacteria, two fungi, and, to a lesser extent, an enveloped virus. Because we purified RatNP-1, -3, and -4 to homogeneity and we used different microbial targets and assay conditions, it is not possible to compare our studies directly with those of Modrzakowski et al. (17, 18, 25, 28) . Nevertheless, our data confirm their report that cationic, lowmolecular-weight antimicrobial peptides exist in rat PMN.
The rat peptides described in this report retain all of the eight framework residues common to the other 10 known members of the defensin family (37, 39, 40) . Six of these conserved amino acids are half-cystines, whose intramolecular disulfide bonds shape and stabilize the fold of the polypeptide backbone. Arginine-15 and glycine-18 are also conserved. Conservation of these eight framework residues, particularly the six half-cystines, provides a hallmark for the defensin family. The disulfide pairing (39a) and the backbone structure of several defensins (4, 32) have been described elsewhere.
In addition to possessing the eight framework residues common to all defensins, rat defensins shared three additional amino acids with their human and rabbit congeners: arginine-6, glutamic acid-14, and glycine-24 (Fig. 3) . When compared with each other, the three rat peptides were homologous in 18 of their 29 to 32 residue positions (Fig. 3) . was remarkably similar to the human defensins. When RatNP-4 (31 residues) was aligned with human HNP-1 (30 residues), 17 amino acids were identical and 7 were conservatively substituted (Fig. 4) . Overall, the sequence homology among these defensins was as follows: rat to rat, 62 to 68% identical; rat to human, 38 to 57% identical; rat to rabbit, 32 to 58% identical; rat to guinea pig, 32 to 42% identical.
Although our limited quantities of purified rat defensins precluded more exhaustive functional testing, our experiments established that members of the newly characterized rat defensin family exerted microbicidal activity against selected gram-positive and gram-negative bacteria and certain fungi in vitro. RatNP-1 appeared to be the most potent of these rat defensins, perhaps because it was also the most cationic. This behavior was consistent with our findings that the relative bactericidal (13, 42) and fungicidal (6, 13, 23, 35, 41) efficacy of human and rabbit defensins correlated with the net positive charge of the peptides. Our finding that stationary-phase S. aiureius was considerably less susceptible to killing by rat defensins than midlogarithmic-phase organisms suggests that target cell growth and/or metabolism modulates susceptibility to rat PMN defensins. We have observed similar results when human PMN defensins were tested against S. aureuis 502A and E. coli ML-35 (unpublished data) and C. albicans (13) .
With this report, a total of 13 defensins have now been found in the PMN of four mammalian species: rabbits, guinea pigs, humans, and rats. It appears that defensins are 6- 
